These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28430609)

  • 1. Characterization of pressure-mediated vascular tone in resistance arteries from bile duct-ligated rats.
    Jadeja RN; Thounaojam MC; Khurana S
    Oncotarget; 2017 May; 8(19):30706-30722. PubMed ID: 28430609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats.
    Naik JS; Xiang L; Hester RL
    Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R154-61. PubMed ID: 16141308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
    Kajita M; Murata T; Horiguchi K; Iizuka M; Hori M; Ozaki H
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1021-31. PubMed ID: 21193589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca
    Jadeja RN; Thounaojam MC; Bartoli M; Khurana S
    Toxicol Appl Pharmacol; 2018 Jun; 348():14-21. PubMed ID: 29660437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries.
    Dubroca C; Loyer X; Retailleau K; Loirand G; Pacaud P; Feron O; Balligand JL; Lévy BI; Heymes C; Henrion D
    Cardiovasc Res; 2007 Jan; 73(1):190-7. PubMed ID: 17150200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodelling and enhanced myogenic tone in cerebral resistance arteries isolated from genetically hypertensive Brattleboro rats.
    Dunn WR; Wallis SJ; Gardiner SM
    J Vasc Res; 1998; 35(1):18-26. PubMed ID: 9482692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
    Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased arterial smooth muscle Ca2+ signaling, vasoconstriction, and myogenic reactivity in Milan hypertensive rats.
    Linde CI; Karashima E; Raina H; Zulian A; Wier WG; Hamlyn JM; Ferrari P; Blaustein MP; Golovina VA
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H611-20. PubMed ID: 22140038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.
    Fiorucci S; Antonelli E; Brancaleone V; Sanpaolo L; Orlandi S; Distrutti E; Acuto G; Clerici C; Baldoni M; Del Soldato P; Morelli A
    J Hepatol; 2003 Dec; 39(6):932-9. PubMed ID: 14642608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
    Trebicka J; Leifeld L; Hennenberg M; Biecker E; Eckhardt A; Fischer N; Pröbsting AS; Clemens C; Lammert F; Sauerbruch T; Heller J
    Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
    Parente JM; Pereira CA; Oliveira-Paula GH; Tanus-Santos JE; Tostes RC; Castro MM
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha.
    Besnard S; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Tedgui A; Henrion D
    Circ Res; 2002 Apr; 90(7):820-5. PubMed ID: 11964376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction.
    Scotland RS; Chauhan S; Davis C; De Felipe C; Hunt S; Kabir J; Kotsonis P; Oh U; Ahluwalia A
    Circ Res; 2004 Nov; 95(10):1027-34. PubMed ID: 15499026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+ profiles and Ca2+ sensitisation of constriction of pressurised rat resistance arteries.
    Shaw L; O'Neill S; Jones CJ; Austin C; Taggart MJ
    Br J Pharmacol; 2004 Feb; 141(4):678-88. PubMed ID: 14744813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway.
    Sun J; Yang T; Wang P; Ma S; Zhu Z; Pu Y; Li L; Zhao Y; Xiong S; Liu D; Zhu Z
    Hypertension; 2014 Jun; 63(6):1354-63. PubMed ID: 24637663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
    Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
    Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.